Neuronetics, Inc. Amended Passive Investment Disclosure
Investor Jorey Chernett filed an amended Schedule 13G reporting his beneficial ownership in Neuronetics, Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Investor Jorey Chernett filed an amended Schedule 13G reporting his beneficial ownership in Neuronetics, Inc. common stock. He reports holding 6,827,031 shares, with sole power to vote and dispose of all of these shares and no shared voting or dispositive power.
This stake exceeds the 5% threshold that requires public disclosure but is certified as not intended to change or influence control of Neuronetics. The filing lists Chernett as a U.S. individual investor and indicates no group, subsidiaries, or other persons on whose behalf the shares are held.
AI-generated analysis. How Rhea-AI works. Not financial advice.